Terrie Curran

2021

In 2021, Terrie Curran earned a total compensation of $6.3M as President and Chief Executive Officer at Phathom Pharmaceuticals, a 35% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$396,257
Option Awards$5,294,273
Salary$567,500
Other$14,625
Total$6,272,655

Curran received $5.3M in option awards, accounting for 84% of the total pay in 2021.

Curran also received $396.3K in non-equity incentive plan, $567.5K in salary and $14.6K in other compensation.

Rankings

In 2021, Terrie Curran's compensation ranked 2,017th out of 12,406 executives tracked by ExecPay. In other words, Curran earned more than 83.7% of executives.

ClassificationRankingPercentile
All
2,017
out of 12,406
84th
Division
Manufacturing
767
out of 5,492
86th
Major group
Chemicals And Allied Products
298
out of 2,368
87th
Industry group
Drugs
257
out of 2,089
88th
Industry
Pharmaceutical Preparations
166
out of 1,536
89th
Source: SEC filing on April 13, 2023.

Curran's colleagues

We found one more compensation record of an executive who worked with Terrie Curran at Phathom Pharmaceuticals in 2021.

2021

Azmi Nabulsi

Phathom Pharmaceuticals

Chief Operating Officer

News

In-depth

You may also like